Tafamidis Capsules bulk supplier for pharma manufacturers

Tafamidis Capsules 20 mg, 61 mg Suppliers & Bulk Manufacturers

Available Forms: Soft capsules

Available Strengths: 20 mg, 61 mg

Pack Sizes: 30 capsules

Reference Brands: Vyndaqel, Vyndamax

Tafamidis is a transthyretin stabiliser used for transthyretin amyloidosis of the heart and nerves. PharmaTradz handles enquiries for tafamidis supply and for API and dossier partners.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Tafamidis Capsules? List it or send an offer →

Product Description:

Tafamidis treats transthyretin amyloidosis (ATTR). Transthyretin is a blood protein that normally travels as a group of four. In ATTR the group falls apart, and the single pieces fold wrongly and build up as amyloid in the heart and nerves. Tafamidis binds to the protein and holds the four pieces together, which slows the disease.

The 61 mg capsule (tafamidis free acid) and 80 mg as four 20 mg capsules (tafamidis meglumine) are used for ATTR cardiomyopathy, where they reduce deaths and heart-related hospital stays. In the EU the 20 mg capsule is also used for early nerve disease (polyneuropathy). It is taken once a day for life, which makes it one of the costliest heart medicines and a frequent named-patient and access request.

Sourcing notes. Tafamidis API is produced by several manufacturers, but patent protection on the finished product differs by country, and in the US generic entry has been delayed by patent settlements. We confirm what can lawfully be supplied for each destination before quoting, and handle innovator supply through authorised routes where needed. Room-temperature storage.

Tafamidis Capsules — third party manufacturing & bulk supply

Tafamidis Capsules 20 mg, 61 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tafamidis Capsules is supplied as Soft capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tafamidis Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tafamidis Capsules →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Tafamidis Capsules is listed as Soft capsules in 20 mg, 61 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Tafamidis Capsules is referenced against Vyndaqel, Vyndamax. Reference brands are shown for identification only and remain the property of their respective trademark owners.